SCHEMBL10094505

SCHEMBL10094505

CC(C)c1cccnc1-c1ccc(S(=O)(=O)N2CCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ GAA P10253 2/20 0.51
▸ OPRK1 P41145 3/20 0.51
▸ TSHR P16473 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ TRPV4 Q9HBA0 1/20 0.48
▸ USP2 O75604 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ HSD11B1 P28845 1/20 0.45
▸ OPRM1 P35372 1/20 0.44
▸ PIK3CD O00329 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ PIK3CB P42338 1/20 0.44
▸ PIK3CG P48736 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094720 0.83 PKM (0.57) ALDH1A1GAAOPRK1TSHRPKM
SCHEMBL15723909 0.80 OPRK1 (0.52) ALDH1A1GAAOPRK1TSHRPKM
SCHEMBL10094586 0.79 ALDH1A1 (0.60) ALDH1A1GAAOPRK1TSHRPKM
SCHEMBL15730143 0.75 PKM (0.57) ALDH1A1GAAOPRK1TSHRPKM
SCHEMBL104325 0.71 MCOLN3 (0.71) ALDH1A1GAATSHRPKMUSP2
SCHEMBL10094460 0.71 SYK (0.45) ALDH1A1GAAKDM4ETDP1L3MBTL1
SCHEMBL10094579 0.70 GABRA1 (0.43) ALDH1A1TSHRKDM4EALOX15HTT
SCHEMBL29857184 0.70 GABRA1 (0.43) ALDH1A1TSHRKDM4EALOX15HTT
SCHEMBL15723900 0.70 GAA (0.56) ALDH1A1GAAUSP2KDM4EHTT
SCHEMBL28882091 0.70 ALDH1A1 (0.69) ALDH1A1GAATSHRPKMUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 ALDH1A1 2989/4885GAA 3707/4885OPRK1 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback